Figshareopen access
<b>Poster presented at EASL 2026: </b>Metabolic matters: real-world assessment of metabolic dysfunction–associated steatotic liver diseases in the United States by integrating international classification of diseases codes and non-invasive tests for improved detection
3. biomedical and clinical sciences, survodutide, gcgr/glp-1r dual agonist, dual agonism, rwe, metabolic dysfunction‑associated steatotic liver disease (masld), non‑invasive tests, icd‑based disease identification
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 226644
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.